Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements

Table 3

Association of GERD and laboratory, demographic data, and elastographic parameters.

	OR	95% CI	value
BMI (kg/m^2)	1.00	0.95–1.05	0.955
Age (years)	1.01	0.99–1.03	0.543
AST (U/L)	1.00	0.99–1.01	0.730
ALT (U/L)	1.01	0.99–1.02	0.358
GGT (U/L)	1.00	0.99–1.00	0.606
Total cholesterol (mmol/L)	1.01	0.97–1.05	0.572
HDL (mmol/L)	0.76	0.40–1.45	0.407
LDL (mmol/L)	0.89	0.69–1.15	0.374
Triglyceride (mmol/L)	0.98	0.87–1.10	0.744
Serum insulin, pmol/L	1.00	0.99–1.01	0.873
Arterial hypertension, n (%)	1.33	0.76–2.34	0.319
Diabetes mellitus, n (%)	1.09	0.63–1.88	0.765
Hyperlipoproteinemia, n (%)	0.89	0.53–1.49	0.661
LSM (kPa)	1.00	0.95–1.06	0.964
CAP (dB/m)	1.01	1.01–1.02	<0.001

BMI: body mass index; AST: aspartate aminotransferase; ALT: alanine aminotransferase; GGT: gamma-glutamyl transferase; HDL: high-density lipoprotein; LSM: liver stiffness measurement; LDL: low-density lipoprotein; CAP: controlled attenuation parameter. .